The economic burden of metastatic breast cancer: A systematic review of literature from developed countries
作者： Talia S. Foster , Jeffrey D. Miller , Mark E. Boye , Marissa B. Blieden , Risha Gidwani
DOI: 10.1016/J.CTRV.2010.12.008
关键词:
摘要: … Worldwide, breast cancer is the leading cause of cancer … Breast cancer is much less common among men, but still strikes … Cancer Society estimates that in 2007, approximately 40,000 …
rti.org
elsevier.com
sci-hub.se 参考文章(76)
John Edelsberg, Thomas Delea, Jane Brandman, Gerry Oster, Monika Raut, Jennifer Sung, James McKiernan, Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice. The journal of supportive oncology. ,vol. 4, pp. 341- 347 ,(2006)
Peter Muennig, Kamran Khan, Designing and conducting cost-effectiveness analyses in medicine and health care ,(2002)
Peter J Neumann, Gillian D Sanders, Louise B Russell, Joanna E Siegel, Theodore G Ganiats, None, Cost-effectiveness in health and medicine Oxford University Press. ,(1996)
Shailendra Verma, Dominique Maraninchi, Joyce O'Shaughnessy, Carol Jamieson, Stephen Jones, Miguel Martín, Joseph McKendrick, David Miles, Chris Twelves, John Hornberger, Capecitabine plus docetaxel combination therapy Cancer. ,vol. 103, pp. 2455- 2465 ,(2005) , 10.1002/CNCR.21122
Nicky J Welton, A Champion, K Francis, M Baker, E Collins, R Dewis, A Bennett, J Gribbin, S Berendse, F Macbeth, A Cleves, B Coles, S Willis, Advanced breast cancer: diagnosis and treatment NICE. ,(2008)
Nagi S El Saghir, Muhieddine Seoud, Mazen K Khalil, Maya Charafeddine, Ziad K Salem, Fady B Geara, Ali I Shamseddine, None, Effects of young age at presentation on survival in breast cancer BMC Cancer. ,vol. 6, pp. 194- 194 ,(2006) , 10.1186/1471-2407-6-194
Lorna Gibson, David Lawrence, Claire Dawson, Judith Bliss, Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women Cochrane Database of Systematic Reviews. ,vol. 2007, pp. 003370- ,(2009) , 10.1002/14651858.CD003370.PUB3
Hirohisa Imai, Katsumasa Kuroi, Shozo Ohsumi, Michikazu Ono, Kojiro Shimozuma, Economic evaluation of the prevention and treatment of breast cancer--present status and open issues. Breast Cancer. ,vol. 14, pp. 81- 87 ,(2007) , 10.2325/JBCS.14.81
Ágnes Benedict, Ruth E Brown, Review of cost-effectiveness analyses in hormonal therapies in advanced breast cancer Expert Opinion on Pharmacotherapy. ,vol. 6, pp. 1789- 1801 ,(2005) , 10.1517/14656566.6.11.1789
Jonathan Karnon, Aromatase Inhibitors in Breast Cancer PharmacoEconomics. ,vol. 24, pp. 215- 232 ,(2006) , 10.2165/00019053-200624030-00002